Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women

被引:248
作者
Lukanova, A
Lundin, E
Zeleniuch-Jacquotte, A
Muti, P
Mure, A
Rinaldi, S
Dossus, L
Micheli, A
Arslan, A
Lenner, P
Shore, RE
Krogh, V
Koenig, KL
Riboli, E
Berrino, F
Hallmans, G
Stattin, P
Toniolo, P
Kaaks, R
机构
[1] Int Agcy Res Canc, Hormones & Canc Grp, F-69372 Lyon, France
[2] Umea Univ Hosp, Dept Publ Hlth & Clin Med Nutrit Res, Umea, Sweden
[3] Umea Univ, Dept Med Biosci & Pathol, Umea, Sweden
[4] NYU, Sch Med, Dept Environm Med, New York, NY USA
[5] SUNY Buffalo, Dept Social & Prevent Med, Sch Med & Biomed Sci, Buffalo, NY USA
[6] Ecole Natl Super Agron Toulouse, Toulouse, France
[7] Ist Nazl Studio & Cura Tumori, Epidemiol Unit, Milan, Italy
[8] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY 10016 USA
[9] Umea Univ Hosp, Dept Oncol, S-90185 Umea, Sweden
[10] Umea Univ Hosp, Dept Urol & Androl, Umea, Sweden
关键词
D O I
10.1530/eje.0.1500161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Excess weight has been associated with increased risk of cancer at several organ sites. In part, this effect may be modulated through alterations in the metabolism of sex steroids and IGF-I related peptides. The objectives of the study were to examine the association of body mass index (BMI) with circulating androgens (testosterone, androstenedione and dehydroepiandrosterone sulfate (DHEAS)), estrogens (estrone and estradiol), sex hormone-binding globulin (SHBG), IGF-I and IGF-binding protein (IGFBP)-3, and the relationship between sex steroids, IGF-I and IGFBP-3. Design and methods: A cross-sectional analysis was performed using hormonal and questionnaire data of 620 healthy women (177 pre- and 443 post-menopausal). The laboratory measurements of the hormones of interest were available from two previous case-control studies on endogenous hormones and cancer risk. Results: In the pre-menopausal group, BMI was not related to androgens and IGF-I. In the post-menopausal group, estrogens, testosterone and androstenedione increased with increasing BMI. The association with IGF-I was non-linear, with the highest mean concentrations observed in women with BMI between 2 4 and 25. In both pre- and post-menopausal subjects, IGFBP-3 did not vary across BMI categories and SHBG decreased with increasing BMI. As for the correlations between peptide and steroid hormones, in the post-menopausal group, IGF-I was positively related to androgens, inversely correlated with SHBG, and not correlated with estrogens. In the pre-menopausal group, similar but weaker correlations between IGF-I and androgens were observed. Conclusions: These observations offer evidence that obesity may influence the levels of endogenous sex-steroid and IGF-related hormones in the circulation, especially after menopause. Circulating IGF-I, androgens and SHBG appear to be related to each other in post-menopausal women.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 69 条
[41]  
Klinger B, 1998, CLIN ENDOCRINOL, V48, P81
[42]   Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance) [J].
Laron, Z ;
Klinger, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (02) :176-180
[43]   Circulating levels of insulin-like growth factor-I and risk of ovarian cancer [J].
Lukanova, A ;
Lundin, E ;
Toniolo, P ;
Micheli, A ;
Akhmedkhanov, A ;
Rinaldi, S ;
Muti, P ;
Lenner, P ;
Biessy, C ;
Krogh, V ;
Zeleniuch-Jacquotte, A ;
Berrino, F ;
Hallmans, G ;
Riboli, E ;
Kaaks, R .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (06) :549-554
[44]   Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 [J].
Lukanova, A ;
Zeleniuch-Jacquotte, A ;
Lundin, E ;
Michel, A ;
Arslan, AA ;
Rinaldi, S ;
Muti, P ;
Lenner, P ;
Koenig, KL ;
Biessy, C ;
Krogh, V ;
Riboli, E ;
Shore, RE ;
Stattin, P ;
Berrino, F ;
Hallmans, C ;
Toniolo, P ;
Kaaks, R .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (02) :262-268
[45]   Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) [J].
Lukanova, A ;
Söderberg, S ;
Stattin, P ;
Palmqvist, R ;
Lundin, E ;
Biessy, C ;
Rinaldi, S ;
Riboli, E ;
Hallmans, G ;
Kaaks, R .
CANCER CAUSES & CONTROL, 2002, 13 (06) :509-516
[46]   A cross-sectional study of IGF-1 determinants in women [J].
Lukanova, A ;
Toniolo, P ;
Akhmedkhanov, A ;
Hunt, K ;
Rinaldi, S ;
Zeleniuch-Jacquotte, A ;
Haley, NJ ;
Riboli, E ;
Stattin, P ;
Lundin, E ;
Kaaks, R .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (05) :443-452
[47]   Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients [J].
Maccario, M ;
Ramunni, J ;
Oleandri, SE ;
Procopio, M ;
Grottoli, S ;
Rossetto, R ;
Savio, P ;
Aimaretti, G ;
Camanni, F ;
Ghigo, E .
INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (06) :612-618
[48]   Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States) [J].
Madigan, MP ;
Troisi, R ;
Potischman, N ;
Dorgan, JF ;
Brinton, LA ;
Hoover, RN .
CANCER CAUSES & CONTROL, 1998, 9 (02) :199-207
[49]   EFFECT OF ESTROGEN STATUS ON SERUM LEVELS OF GROWTH HORMONE-BINDING PROTEIN AND INSULIN-LIKE GROWTH FACTOR-I IN NONPREGNANT AND PREGNANT-WOMEN [J].
MASSA, G ;
IGOUT, A ;
ROMBAUTS, L ;
FRANKENNE, F ;
VANDERSCHUERENLODEWEYCKX, M .
CLINICAL ENDOCRINOLOGY, 1993, 39 (05) :569-575
[50]   The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model [J].
McGee, EA ;
Sawetawan, C ;
Bird, I ;
Rainey, WE ;
Carr, BR .
FERTILITY AND STERILITY, 1996, 65 (01) :87-93